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Traditionally, myelin is viewed as insulation around axons, however, more recent
studies have shown it also plays an important role in plasticity, axonal metabolism,
and neuroimmune signaling. Myelin is a complex multi-protein structure composed
of hundreds of proteins, with Myelin Basic Protein (MBP) being the most studied.
MBP has two families: Classic-MBP that is necessary for activity driven compaction
of myelin around axons, and Golli-MBP that is found in neurons, oligodendrocytes,
and T-cells. Furthermore, Golli-MBP has been called a “molecular link” between the
nervous and immune systems. In visual cortex specifically, myelin proteins interact
with immune processes to affect experience-dependent plasticity. We studied myelin in
human visual cortex usingWestern blotting to quantify Classic- andGolli-MBP expression
in post-mortem tissue samples ranging in age from 20 days to 80 years. We found
that Classic- and Golli-MBP have different patterns of change across the lifespan.
Classic-MBP gradually increases to 42 years and then declines into aging. Golli-MBP
has early developmental changes that are coincident with milestones in visual system
sensitive period, and gradually increases into aging. There are three stages in the balance
between Classic- and Golli-MBP expression, with Golli-MBP dominating early, then
shifting to Classic-MBP, and back to Golli-MBP in aging. Also Golli-MBP has a wave
of high inter-individual variability during childhood. These results about cortical MBP
expression are timely because they compliment recent advances in MRI techniques that
produce high resolution maps of cortical myelin in normal and diseased brain. In addition,
the unique pattern of Golli-MBP expression across the lifespan suggests that it supports
high levels of neuroimmune interaction in cortical development and in aging.
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Introduction
The last decade has seen renewed interest in studying myelin in the cortex because it is involved
in neuroplasticity, neurodegeneration, and neuroinflammation. As maturation of cortical myelin
limits developmental plasticity (McGee et al., 2005), changes in aging are linked with cognitive
decline (Peters et al., 2008), and myelin abnormalities contribute to neurodegenerative and neu-
ropsychiatric disease (Roussos and Haroutunian, 2014; Mighdoll et al., 2015). Novel brain imaging
techniques are producing high resolution maps of myelin in human cortex (Glasser and van Essen,
2011; Grydeland et al., 2013; Shafee et al., 2015) that can follow these changes in cortical myelin
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during adaptive or maladaptive plasticity. Myelin, however, is
a complex multi-protein structure and we need to know more
about the expression of proteins that make up myelin in the
human cortex to link these new brain imaging techniques with
disease-related changes in myelin proteins.
In the cortex, oligodendrocytes are the second most abundant
type of neuroglial cell and they formmyelin. Myelin is made up of
hundreds of proteins, many of which have multiple families and
isoforms. The most commonly used marker for myelin expres-
sion is Myelin Basic Protein (MBP). MBPmakes up about 30% of
all myelin proteins and is composed of two families, Classic- and
Golli-MBP, each with multiple isoforms and post-translational
modifications (Pribyl et al., 1996; Harauz et al., 2009; Harauz and
Boggs, 2013) that individually contribute to myelination (Jacobs
et al., 2005, 2009; Harauz et al., 2009). Classic-MBP isoforms
(18.5–21.5 kDa in human) are found in mature oligodendrocytes
and myelin sheaths, and have a key role in activity driven com-
paction ofmyelin around axons (Wake et al., 2011). Expression of
Classic-MBP increases during cortical development (Miller et al.,
2012) and immunohistochemical labeling of Classic-MBP is cor-
related with traditional myelin staining. In contrast, Golli-MBP
isoforms (33–35 kDa) are found in early developing oligoden-
drocytes, neurons and immune cells, with functions that extend
beyond the myelin sheath and include regulating oligodendro-
cyte proliferation and migration (Paez et al., 2011). Golli-MBP
is highly expressed prenatally in neurons and oligodendrocytes,
even before the process of myelination begins (Tosic et al., 2002)
and has been called a “molecular link” between the nervous and
immune systems (Pribyl et al., 1993).
The primary sensory cortices are heavily myelinated (Geyer
et al., 2011) and are good cortical regions to study develop-
mental changes in expression of both families of MBP. Expres-
sion of MBP and myelination in the visual cortex is affected
by neuropsychiatric disease and genetic manipulation of Golli-
MBP. In schizophrenia, there is reduced MBP mRNA in human
visual cortex, as well as other cortical areas, suggesting that
MBP expression in visual cortex is vulnerable to neuropsychi-
atric disease (Matthews et al., 2012). Furthermore, abnormalities
in genes that code for Golli-MBP are linked with significant risk
for schizophrenia (Baruch et al., 2009). Although Golli-MBP is
not part of the myelin sheath, it is necessary for normal devel-
opment of myelination (Jacobs et al., 2005). Golli-MBP knock-
out (KO) mice have an abnormal balance between Golli- and
Classic-MBP that leads to profound hypomyelination restricted
to the visual cortex (Jacobs et al., 2005).While Golli-MBP overex-
pressing mice have delayed development of myelination (Jacobs
et al., 2009). Several lines of evidence have linked myelin (McGee
et al., 2005) and neuroimmune signaling (Syken et al., 2006) with
the end of the sensitive period in the visual cortex. Since Golli-
MBP has been called a “molecular link” between the nervous and
immune systems (Pribyl et al., 1993) it is timely to characterize its
expression in human visual cortex.
To address how the two families of MBP proteins change
across the lifespan, we used Western blotting to quantify expres-
sion of Classic- and Golli-MBP in post-mortem tissue samples
from human primary visual cortex. We used model fitting to
characterize developmental trajectories that capture how Classic-
and Golli-MBP change across the lifespan. We analyzed changes
in the relative expression of Classic- and Golli-MBP to determine
how the balance between these families of MBP vary in human
visual cortex. Finally, we compared inter-individual variability in
expression of Classic- and Golli-MBP to determine if there are
times in development with higher inter-individual variability.
Materials and Methods
Samples and Tissue
Tissue samples from human primary visual cortex were obtained
from the Brain and Tissue Bank for Developmental Disorders
at the University of Maryland (Baltimore, MD, USA) and were
approved for use by the McMaster University Research Ethics
Board. Samples were taken from the posterior pole of the left
hemisphere of human visual cortex, and included both supe-
rior and inferior portions of the calcarine fissure, according to
the gyral and sulcal landmarks. Cortical samples were obtained
from individuals with no history of mental health or neurological
disorders, and all causes of death were natural, or with mini-
mal trauma. Samples were obtained within 23 h post-mortem,
and were rapidly frozen at the Brain and Tissue Bank after being
sectioned coronally in 1-cm intervals, rinsed with water, blotted
dry, placed in a quick-freeze bath (dry ice and isopentane), and
stored frozen (−80◦C). A total of 31 cases were used in this study,
ranging in age from 20 days to 79 years (Table 1).
Tissue-Sample Preparation
Small pieces of tissue samples (75–150mg) were cut from 1-cm
thick coronal slices of primary visual cortex (area V1), and sus-
pended in cold homogenization buffer (1ml buffer:50mg tis-
sue; 0.5mM DTT, 1mM EDTA, 2mM EGTA, 10mM HEPES,
10mg/L leupeptin, 100 nM microcystin, 0.1mM PMSF, 50mg/L
soybean trypsin inhibitor). Samples were homogenized using the
FastPrep R©−24 Tissue and Cell Homogenizer (MP Biomedicals,
Solon, OH, USA) by placing the piece of tissue and buffer in a
lysing matrix D homogenization tube (MP Biomedicals, Solon,
OH, USA) and homogenizing for 40 s at 6/ms. After homoge-
nization, sodium-dodecyl-sulfate 10% (SDS) was added to each
sample to further unravel proteins in preparation for gel elec-
trophoresis. Total protein concentrations were determined using
a bicinchonic acid (BCA) assay (Pierce, Rockford, IL, USA). A
control sample was made by combining a small amount of the
homogenized tissue sample from each case.
Immunoblotting
Homogenized tissue samples (20µg) were separated on SDS
polyacrylamide gels (SDS-PAGE) and transferred to polyvinyli-
dene difluoride (PVDF-FL) membranes (Millipore, Billerica,
MA, USA) using electroblotting in BupH Tris Glycine Transfer
Buffer (Thermo Scientific, Waltham, MA, USA). Each sample
was run 3 times. Each blot was loaded with a protein stan-
dards ladder and a control sample. Blots were pre-incubated for
1 h in blocking buffer (Odyssey Blocking Buffer 1:1 with PBS;
Li-cor Biosciences; Lincoln, NE, USA), then in primary anti-
body overnight at 4◦C using the following concentrations: Anti-
GAPDH, 1:8000 (Imgenex, San Diego, CA); Anti-β-Tubulin,
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TABLE 1 | Cases used in the study.
Age group Age Post-mortem interval (H) Sex
Neonatal 20 days 9 M
Neonatal 20 days 14 F
Neonatal 86 days 23 F
Neonatal 96 days 12 M
Neonatal 98 days 16 M
Neonatal 119 days 22 M
Neonatal 120 days 23 M
Infant 133 days 16 M
Infant 136 days 11 F
Infant 273 days 10 M
Young Children 1 year 123 days 21 M
Young Children 2 years 57 days 21 F
Young Children 2 years 75 days 11 F
Young Children 3 years 123 days 11 F
Young Children 4 years 203 days 15 M
Young Children 4 years 258 days 17 M
Older Children 5 years 144 days 17 M
Older Children 8 years 50 days 20 F
Older Children 8 years 214 days 20 F
Older Children 9 years 46 days 20 F
Teens 12 years 164 days 22 M
Teens 13 years 99 days 5 M
Teens 15 years 81 days 16 M
Teens 19 years 76 days 16 F
Young Adults 22 years 359 days 4 M
Young Adults 32 years 223 days 13 M
Young Adults 50 years 156 days 8 M
Young Adults 53 years 330 days 5 F
Older Adults 69 years 110 days 12 M
Older Adults 71 years 333 days 9 F
Older Adults 79 years 181 days 14 F
1:4000 (Imgenex, San Diego, CA); Anti-Myelin Basic Protein
(MBP), 1:4000 [AB62631] (Abcam, Cambridge, MA, USA). The
blots were washed with PBS containing 0.05% Tween (Sigma,
St. Louis, MO, USA) (3 × 10min), and incubated for 1 h with
the appropriate secondary antibody (1:8000 IRDye, Li-cor Bio-
sciences, Lincoln, NE, USA). The blots were washed again in
PBS-Tween (3 × 10min) and bands were visualized using the
Odyssey scanner (Li-cor Biosciences, Lincoln, NE, USA). The
blots were stripped (Blot Restore Membrane Rejuvenation kit,
Millipore, Billerica, MA, USA) and then reprobed with another
primary antibody.
Analyses
To quantify protein expression, blots were scanned using
Odyssey Infrared Imaging System (Li-cor Biosciences, Lincoln,
NE, USA) and the bands were quantified using densitometry (Li-
cor Odyssey Software Version 3.0, Li-cor Biosciences, Lincoln,
NE, USA). The density of each band was determined by subtract-
ing the background, integrating the pixel intensity of the band,
and dividing that intensity by the width of the band to control for
variations in lane width. GAPDHwas used as the loading control
in this study after determining that GAPDH expression was not
affected by either age or length of post-mortem interval (PMI, see
Results). The expression of Classic- and Golli-MBP in each lane
of the blot was divided by GAPDH expression in the same lane.
To compare protein expression levels across blots, a control sam-
ple (mixture of all samples) was run on every gel, and for each
sample on a blot the density was normalized to the density of the
control sample. Finally, for each MBP protein, expression levels
across runs were normalized using the average expression of the
protein.
To analyze the developmental changes in Classic–and Golli-
MBP we began by plotting scatterplots, showing the results from
every run (gray dots) as well as the average for each sample
(black dots), and histograms binning all the data into different
age groups. We applied a model-fitting approach (Christopou-
los and Lew, 2000) to determine the best fitting curve to the data
presented in the scatterplots (gray dots) using Matlab. Significant
curve fits are plotted on the scatterplots. We found that quadratic
functions were good fits to each data set (y =PeakExp + A∗(x -
PeakAge)ˆ2) and the best fitting curves were determined by least
squares giving the goodness-of-fit (R), statistical significance of
the fit (p), and 95% confidence interval (CI) for the age at the peak
of the function. The age whenmature levels of protein expression
were reached was calculated from the parameters of the curve-fits
and was defined as the age when protein expression first reached
90% of peak expression.
We compared differences among developmental stages by
binning the data into the following age groups: neonatal (<0.4
years), infants (0.4–1 years), young children (1–4 years), older
children (5–11 years), teens (12–20 years), young adults (21–
55 years), and older adults (>55 years). Histograms were plot-
ted using the mean and standard error of the mean (SEM) for
each age bin. Statistical comparisons among age groups were
made using an analysis of variance (ANOVA) and when signif-
icant (p < 0.05), Tukey’s post-hoc comparisons were done to
determine which age groups were significantly different.
We quantified changes in the relative expression of Classic–to
Golli-MBP by calculating an index using the formula (Classic-
MBP - Golli-MBP)/(Classic-MBP + Golli-MBP). The two fami-
lies of MBP are genetically and functionally related so this index
provides information about their combined development. The
index can vary from −1 to +1 and this type of contrast index
is commonly used in signal processes to reduce noise. Here we
applied the index to analyze the balance between Classic- and
Golli-MBP across the lifespan, where negative values represent
more Golli-MBP and positive values more Classic-MBP. The
index was plotted as described above. Briefly, a quadratic func-
tion was fit to all the index data and an analysis of variance was
done to compare changes in the index among age bins.
In a previous study, we identified stages in cortical devel-
opment when there was high inter-individual variability in the
expression of various synaptic proteins (Pinto et al., 2015). We
applied the same approach in this study to examine changes in
inter-individual variability in expression of Classic- and Golli-
MBP by calculating the Fano Factor (Variance-to-Mean Ratio,
VMR) for eachMBP protein. The VMR at each age was calculated
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using the average protein expression for each case and deter-
mining the mean and variance in expression within a window
that included the case and the two adjacent ages. The VMRs for
Classic- and Golli-MBP were plotted as scatterplots to visualize
whether there are ages in development with high inter-individual
variability.
Results
Loading Control and Postmortem Interval
Our first step was to determine the best loading control for
this study by quantifying expression of the two most commonly
used loading controls, GAPDH and β-Tubulin. We were look-
ing for a loading control that had similar expression in human
visual cortex across all ages. We found that β-Tubulin declined
across the lifespan (Figure 1A; R = 0.5669, p < 0.0001;
Figure 1B; ANOVA, F = 18.71, p < 0.0001). In contrast,
GAPDH expression did not change across the lifespan as nei-
ther the ANOVA or curve-fits were significant (Figures 1C,D),
therefore we selected GAPDH to use as the loading control.
Next, we compared GAPDH expression with PMI and found no
effect of the length of PMI on GAPDH expression (R = 0.05,
n.s.). Finally, we assessed the effect of PMI on expression of
Classic- and Golli-MBP to determine if any samples needed to
be removed because the PMI was too long. We found no corre-
lation with PMI for either myelin protein (Classic: R = 0.307,
n.s.; Golli: R = 0.143, n.s.) so all samples were included in the
study.
Developmental of Classic- and Golli-MBP
To study Classic- and Golli-MBP expression in human visual
cortex, we used two approaches: model fitting to describe the
developmental trajectories, and age binning of the data to com-
pare among stages of development. We found a gradual increase
in expression of Classic-MBP that continued into adult years,
before a roll off in aging. That trajectory was well fit by a
quadratic function (y= 1.999−0.0008182∗(x-42.01)ˆ2; R = 0.59,
p < 0.0001) showing that Classic-MBP rose through develop-
ment, increasing about 4-fold to the peak of expression at 42 years
(95% CI ± 4.26 years) (Figure 2A). We defined the age when
FIGURE 1 | β-Tubulin and GAPDH expression levels in human
primary visual cortex across the lifespan. Expression levels of
β-Tubulin (A,B) and GAPDH (C,D) are relative to control, and plotted in
scatterplots and age-grouped histograms. In the scatterplots (A,C), gray
symbols indicate values from individual runs, black symbols indicate the
average between runs. Age is plotted on a logarithmic scale. Example
bands from representative Western blots are pictured above. In the
histograms (B,D), developmental age group means and standard error for
each group are plotted. (A) A quadratic function was fit to all β-Tubulin
data points across the lifespan (R = 0.567, p < 0.0001). (B) Significant
differences among age groups are identified (ANOVA, F = 18.715,
p < 0.0001), and Tukey’s post-hoc comparisons were made between
groups (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). (C) There was
no significant change in GAPDH expression across the lifespan. (D) There
were no significant differences in expression of GAPDH among the
developmental age groups.
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FIGURE 2 | Classic- and Golli-MBP expression levels in human
primary visual cortex across the lifespan. Expression levels of
Classic-MBP (A,B) and Golli-MBP (C,D) are relative to control, and plotted in
scatterplots and age-grouped histograms. In the scatterplots (A,C), gray
symbols indicate values from individual runs, black symbols indicate the
average between runs. Age is plotted on a logarithmic scale. Example bands
from representative Western blots are pictured above. In the histograms
(B,D), developmental age group means and standard error for each group
are plotted. (A) A quadratic function was fit to all Classic-MBP data points
across the lifespan (R = 0.59, p < 0.0001). A peak in expression of
Classic-MBP was reached at 42 years of age (peak = 42 years 95% CI +/ =
4.26 years). (B) Significant differences among age groups are identified
(ANOVA, F = 10.248, p < 0.0001), and Tukey’s post-hoc comparisons were
made between groups (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
(C) An inverse quadratic function was fit to all the Golli-MBP data points
older than 0.4 years of age (R = 0.61; p < 0.0001). The minimum expression
was reached at about 10 years of age (minimum = 10.3 years 95% CI ± 3.8
years). (D) Significant differences among age groups are identified (ANOVA,
F = 10.955, p < 0.0001), and Tukey’s post-hoc comparisons were made
between groups (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
Classic-MBP matures as the age when expression reached 90% of
the peak. For Classic-MBP that occurred at about 38 years of age
showing the very slow and prolonged development of this myelin
protein in human visual cortex.
We compared expression of Classic-MBP across developmen-
tal stages and found significant differences among the various
stages (ANOVA; F = 10.25; p < 0.0001) (Figure 2B). Classic-
MBP expression in neonates (<0.4 years) was less than all of the
other age groups (Figure 2B; p-values range 0.0001–0.01). There
was a jump in expression between neonates and infants (0.4–1
year) (p < 0.01), another significant increase between children
(5–12 years) and young adults (20–55 years) (p < 0.01), fol-
lowed by a trend to decline into aging (>55 years) (p = 0.14).
Together, the curve-fitting and developmental stage comparisons
showed that Classic-MBP in human visual cortex had prolonged
development and substantial increase in expression.
The developmental trajectory for Golli-MBP was very differ-
ent from Classic-MBP. Golli-MBP expression was very low in
neonates (<0.4 years) and increased abruptly in slightly older
infants. This early postnatal jump in Golli-MBP could be seen in
both the scatterplot and age binned histogram (Figures 2C,D).
Because of this pattern, we chose to apply model fitting to ana-
lyze development for cases older than 0.4 years of age. Expres-
sion of Golli-MBP expression for cases older than 0.4 years
was well fit by an inverse quadratic function (y = 0.6301 +
0.15∗(log(x)-log(10.31))ˆ2; R = 0.61; p < 0.0001) (Figure 2C).
Golli-MBP expression dropped from high levels to reach a
minimum at about 10 years of age (Figure 2C; minimum =
10.3 years 95% CI ± 3.8) and then increased through adults
into aging. Analysis of the age binned groups found similar
results (Figure 2D; ANOVA; F = 10.95, p < 0.0001). Golli-
MBP expression in infants (0.4–1 year) was significantly higher
than all of the other age groups (Figure 2D; p-values range <
0.0001–0.01). Children (5–12 years) had the lowest level of Golli-
MBP followed by a 2-fold increase in expression into aging
(p < 0.0001). Thus, the rate of development of Golli- was
faster than Classic-MBP, the peaks were at different ages, Golli-
decreased while Classic-MBP increased through childhood, then
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they flipped and Golli- increased while Classic-MBP decreased
into aging.
Balance between Classic- and Golli-MBP
Often changes in Classic- and Golli-MBP are described as mov-
ing in opposite directions. Even the current results, especially the
histograms (Figures 2B,D) appeared to be complementary, but
when we analyzed the relationship between Classic- and Golli-
MBP we found no correlation (R = 0.177, n.s.), suggesting
that there is no simple linear relationship for the amount of
protein expressed by these two MBP families. However, there
is a functional link between Golli- and Classic-MBP through
calcium signaling (Paez et al., 2009; Smith et al., 2011), and
in addition Golli-MBP KO mice have profound hypomyelina-
tion in the visual cortex (Jacobs et al., 2005). Those two find-
ings provide evidence of a relationship, and so we analyzed
the relative expression of Classic-to-Golli-MBP. We calculated
an index [(Classic-MBP − Golli-MBP)/(Classic-MBP + Golli-
MBP)] that could vary from −1 (only Golli-MBP) to +1 (only
Classic-MBP) and provided information about how the balance
between Classic- and Golli-MBP changed in human visual cor-
tex across the lifespan. The scatterplot and age binned histogram
of the Classic-to-Golli-MBP index showed gradual changes that
continued across the entire lifespan (Figures 3A,B). A quadratic
function was a good fit to the index results (y = 0.6308-
0.0006492∗(x-38.92)ˆ2; R = 0.65, p < 0.0001) and captured the
gradual shift frommore Golli- to more Classic-MBP, then back to
relatively more Golli-MBP in older adults (Figure 3A). The func-
tion crossed from more Golli- to more Classic-MBP at 7.6 years
of age, reached a peak with more Classic-MBP at about 38 years
of age (38.3 years, 95% CI ± 2.7 years) and crossed back to more
Golli-MBP at about 68 years (Figure 3A). There were also sig-
nificant differences among the developmental stages (Figure 3B;
ANOVA, F = 16.35, p < 0.0001). Teens (12–20 years) and young
adults (20–55 years) had relatively more Classic-MBP than the
other age groups. The initial shift in the index was driven by
the more rapid loss of Golli-MBP, then the switch to Classic-
MBP by the prolonged increase in Classic-, and the change
into aging by complementary decrease and increase in Classic-
and Golli-MBP, respectively. These results suggest three phases
of development, an early stage (<8 years) when Golli-MBP is
changing, an intermediate stage (8–67 years) when Classic-MBP
changes and a late stage (>68 years) when both families of MBP
change.
Inter-Individual Variability
In our recent paper, we discovered stages in development of
human visual cortex when there was a high degree of inter-
individual variability in expression of synaptic proteins (Pinto
et al., 2015). To assess if Classic- or Golli-MBP had similar
waves of inter-individual variability we calculated the Fano fac-
tor (Variance-to-Mean Ratio, VMR) for a running window of
three adjacent ages for each protein, and plotted the VMR
across the lifespan. The VMR for Classic-MBP was low at all
ages, suggesting that there was little inter-individual variability
in expression of Classic-MBP in visual cortex (Figure 4A). In
contrast, Golli-MBP had a period with higher inter-individual
variability between about 0.4 and 5 years of age that peaked
at 1.4 years (y = 0.920387∗exp(−0.285089/x−0.151975∗x)
(Figure 4B). These findings highlight another way that expres-
sion of the two families of MBP differ and raises the possibility
that the wave of high inter-individual variability for Golli-MBP
reflects a period of vulnerability in development of human visual
cortex.
Discussion
The changes in Classic- and Golli-MBP found in this study of
human visual cortex highlight the complex nature of myelin
expression in the brain. We found that these two families of MBP
FIGURE 3 | Developmental changes of Classic- to Golli-MBP Index
across the lifespan in human visual cortex. Expression of the index
results between Classic- and Golli-MBP are presented in a scatterplot (A),
where gray symbols indicate values from individual runs and black symbols
indicate values indicate the average between runs. Age is plotted on a
logarithmic scale. In a histogram (B), developmental age group means and
standard error of the index results in each group are plotted. (A) A quadratic
function was fit to all the Classic:Golli index data points (R = 0.653,
p < 0.0001), and shows a shift to relatively more Classic-MBP at 7.6 years,
shows peak Classic-MBP expression at 38 years (38.3 years, 95% CI ± 2.7
years), and more Golli-MBP at 68 years of age. (B) Significant differences
among age groups are identified (ANOVA, F = 16.35, p < 0.0001) and
Tukey’s post-hoc comparisons were made between groups (*p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001).
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FIGURE 4 | Development of the Variance-to-Mean Ratio (VMR) for Classic-MBP (A) and Golli-MBP (B). (A) Classic-MBP had no change in VMR across the
lifespan. (B) A quadratic function was fit to all Golli-MBP VMR data points, and had a period of high VMR early on with a peak at about 1.4 years of age.
follow different developmental trajectories, have three stages of
a Classic:Golli balance, and only Golli-MBP has high inter-
individual variability during childhood. We have three main
conclusions from this study.
Different Developmental Trajectories for Classic-
and Golli-MBP in Human Visual Cortex
First, Classic- and Golli-MBP follow different trajectories dur-
ing development and aging of human visual cortex. Classic-MBP
had a prolonged period of development that extended well into
adulthood and then declined into aging. The pattern of pro-
longed development is consistent with findings from anatomical
and brain imaging studies of myelin in human cortex. Anatom-
ical measurements of myelin sheath density from postmortem
human cortex showed that maturation continued well into the
third decade of life (Miller et al., 2012). Brain imaging of myelin
content in human cortex also showed that gray matter myelin
continued to increase into adulthood (Grydeland et al., 2013;
Shafee et al., 2015). Together, those results confirm that myelin
development in human visual cortex extends well beyond the
window of time (6–10 years of age) that represents the end of the
sensitive period for development of lazy-eye (amblyopia) (Epel-
baum et al., 1993; Keech and Kutschke, 1995; Lewis and Mau-
rer, 2005). Our study also identified that Classic-MBP expression
continued to change in older adults by declining into aging. The
loss of Classic-MBP into aging is similar to findings from in vivo
imaging of cortical myelin (Grydeland et al., 2013) and may
be related to degeneration of myelin sheath integrity in aging
monkey visual cortex (Peters et al., 2008).
The development of Golli-MBP was different from Classic-
MBP providing additional evidence that the various myelin pro-
teins follow different developmental trajectories (Miller et al.,
2012). We found an abrupt increase in Golli-MBP at about 4–6
months of age, a peak around 1 year followed by a decline to the
minimum level at about 10 years, and then a gradual increase into
aging. The abrupt increase in Golli-MBP corresponds with the
start of the sensitive period for development of binocular vision
(Banks et al., 1975) and matches the timing of rapid changes in
the balances among pre- and post-synaptic proteins in human
visual cortex (Pinto et al., 2015). Perhaps the coincidence in
timing of abrupt changes in Golli-MBP and synaptic proteins
helps to trigger the start of a period of heightened plasticity when
visual experience readily sculpts maturation of circuits in the
visual cortex.
It is interesting to consider how the early changes in
Golli-MBP could contribute to mechanisms that facilitate and
limit experience-dependent plasticity in the developing visual
cortex. We chose to study Golli-MBP because it has been called
a “molecular link” between the nervous and immune systems
(Pribyl et al., 1993), and its functions during neural develop-
ment are consistent with Golli-MBP contributing to sensitive
period plasticity. Golli-MBP is found in developing oligodendro-
cytes (Campagnoni et al., 1993), neurons (Landry et al., 1996),
T-cells (Feng et al., 2000, 2004) and macrophages (Papenfuss
et al., 2007), and is a major regulatory protein for calcium
influx into both oligodendrocytes (Paez et al., 2007) and T-
cells (Feng et al., 2004). Its expression during early development
increases cell migration, proliferation, extension, and retrac-
tion which contributes to maturation of neuroglia (Paez et al.,
2009) and is consistent with supporting developmental plastic-
ity. Golli-MBP is an intrinsically disordered protein that provides
many sites for protein-protein interactions (Ahmed et al., 2007)
that may be candidate sites to mediate experience-dependent
plasticity.
At the other end of the lifespan, we found an age-related
increase of Golli-MBP in visual cortex. Golli-MBP plays an
important role in myelin repair, since Golli over-expressing mice
have increased survival and proliferation of remyelinating oligo-
dendrocytes (Paez et al., 2012). The age-related increase in Golli-
MBP may reflect an increase in oligodendrocytes and changes
in myelination such as thicker and shorter myelin segments
that have been found in visual cortex of old monkeys (Peters
et al., 2001, 2008; Peters and Sethares, 2004). Therefore, as a
molecular link between the nervous and immune systems, Golli-
MBP may bridge those systems and contribute to neuroim-
mune driven neurodegenerative diseases. Unfortunately, there
have been no studies of Golli-MBP function in the aging brain
and to the best of our knowledge our finding of increased Golli-
MBP expression in human visual cortex is the first report of
Golli-MBP in the aging brain. Clearly, more studies are needed
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to determine how Golli-MBP functions in the aging cortex
and what role it plays in neuroimmune processes involved in
neurodegeneration.
Three Stages of MBP Development
Our second conclusion is that the balance between Classic- and
Golli-MBP in human visual cortex has three stages. We found
an early stage during childhood (<8 years) when Golli-MBP
dominated, an intermediate stage (8–67 years) when there was
more Classic-MBP, and a late stage (>68 years) that shifted back
to more Golli-MBP. The three stages were driven by the dif-
ferent trajectories for Classic- and Golli-MBP. The early stage
was marked by rapid changes in Golli-MBP expression while
the intermediate stage had relatively constant Golli- and grad-
ually increasing Classic-MBP. Finally, the aging stage reflected
both an increase of Golli- and loss of Classic-MBP. Examining
the balance between Classic- and Golli-MBP is a new way to
study MBP changes across the lifespan and although these pro-
teins do not interact directly, Golli-MBP can affect expression
of Classic-MBP. For example, over-expression of Golli-MBP sig-
nificantly delays expression of Classic-MBP and the process of
myelination, (Jacobs et al., 2009) while knocking out Golli causes
permanent hypomyelination of the visual cortex (Jacobs et al.,
2005). Perhaps, higher expression of Golli-MBP during develop-
ment of human visual cortex delays myelination, thereby holding
off one of the brakes on critical period plasticity (McGee et al.,
2005).
The timing of the shift to more Classic-MBP corresponds
with the end of the sensitive period for development of ambly-
opia in children (Epelbaum et al., 1993; Keech and Kutschke,
1995; Lewis and Maurer, 2005). That stage of the Classic-:Golli-
MBP balance may contribute to a period of stability in the visual
cortex as Classic-MBP expression increases into adulthood. Tra-
ditionally, myelination is viewed as supporting signal transduc-
tion by enabling saltatory propagation of neural impulses. More
recently, myelin has been shown to be important for support-
ing (Fields, 2005, 2014) or limiting synaptic plasticity (McGee
et al., 2005), and transporting metabolites to axons (Saab et al.,
2013; Nave and Werner, 2014). Glutamate release promotes
formation of the myelin sheath around axons and increases syn-
thesis of Classic-MBP thereby linking myelination with electri-
cally active axons (Wake et al., 2011). In our recent study of
synaptic proteins in human visual cortex (Pinto et al., 2015),
we found that the glutamate receptor scaffolding protein, PSD-
95, increases during late childhood at a similar point in devel-
opment when Classic-MBP expression takes off. Interestingly,
Classic-MBP has an SH3 ligand that can bind to the SH3 bind-
ing site on PSD-95 (Polverini et al., 2008), thereby providing a
mechanismwhere Classic-MBPmay contribute to SH3-mediated
establishment of a stable lattice of PSD-95 molecules at the post-
synaptic density (Sturgill et al., 2009). Myelin also functions to
supply axons with metabolites and neurotrophic factors that are
necessary to maintain healthy neural connections (Nave and
Werner, 2014). These two lines of evidence suggest that the stage
when Classic-MBP dominates is driven by an increase in exci-
tatory activity and supports a period of optimal axonal energy
metabolism.
The late stage of the Classic-:Golli-MBP balance was the
shift to relatively more Golli-MBP. There have been no stud-
ies of Golli-MBP function in the aging cortex, but its roles in
demyelination and remyelination (Paez et al., 2012), andmultiple
sites for protein-protein interactions make it an ideal candidate
for regulating changes to myelination in the aging cortex. In
addition, this loss of Classic-MBP suggests that one component
of impaired circuit function in the aging cortex may be reduced
metabolic support for axons.
A Wave of Golli-MBP Inter-Individual Variability
during Childhood
Our third conclusion is that Golli-MBP goes through a period
of high inter-individual variability in childhood. In our previous
study of synaptic protein development in human visual cortex,
we found protein specific waves of high inter-individual vari-
ability throughout childhood (Pinto et al., 2015). In the current
study, only Golli-MBP had a wave of high inter-individual vari-
ability in childhood, while Classic-MBP had low variability across
the lifespan. The timing of the wave of Golli-MBP variability was
similar to the wave for PSD-95 (Pinto et al., 2015) with both being
low in neonates, high during infancy and childhood, then drop-
ping to low levels in adults. The difference in variability between
Golli- and Classic-MBP suggests that Golli-MBP expression is
more dynamic than myelin structural proteins such as Classic-
MBP. Since Golli-MBP is involved in signaling between neurons,
oligodendrocytes, and immune cells, the wave of variability in
childhood is likely a complex interaction reflecting a period of
vulnerability between neural and immune systems. Perhaps it is
linked to the high risk of infection during childhood. In contrast,
we were surprised by the lack of inter-individual variability for
Golli-MBP in aging, especially since neuroimmune regulation is
impaired in age-related neurodegeneration (Frank-Cannon et al.,
2009).
Studying Myelin in Visual Cortex
Myelin proteins bind to Nogo and PirB receptors to inhibit axon
regeneration (Hu and Strittmatter, 2004; Atwal et al., 2008), and
in the visual cortex both of those receptors limit experience-
dependent plasticity (McGee and Strittmatter, 2003; Syken et al.,
2006). Mutations to or blocking either Nogo-66 or PirB recep-
tors allow ocular dominance plasticity to continue into adulthood
(McGee et al., 2005; Syken et al., 2006; Bochner et al., 2014) show-
ing a link between myelin proteins, neuroimmune processes, and
visual experience-dependent plasticity. Over-expression of Golli-
MBP significantly delays myelination (Jacobs et al., 2009) while
knocking out Golli-MBP causes profound hypomyelination that
is restricted to the visual cortex (Jacobs et al., 2005). Thus, both
too much or no Golli-MBP affect myelination. The specific effect
of knocking out Golli-MBP on myelination of the visual cortex
suggests that it plays a special role in maturation of that cortical
area.
In this study, we found that the shift from more Golli- to
more Classic-MBP in human visual cortex coincides with the end
of the sensitive period for development of amblyopia. Futher-
more, MBPmRNA is reduced in the visual cortex of patients with
Frontiers in Neuroscience | www.frontiersin.org 8 April 2015 | Volume 9 | Article 138
Siu et al. MBP development in human cortex
schizophrenia (Matthews et al., 2012) suggesting that it may con-
tribute to the pathophysiology underlying changes in their visual
perception. Thus, the visual cortex is an interesting cortical area
for studying the role of myelin proteins in disease.
Previous studies of myelin in the human brain have focused
on white matter maturation (e.g., Paus, 2010; Guleria and Kelly,
2014) and diseases related to changes in the white matter (Fields,
2008). In contrast, our study quantified Classic- and Golli-MBP
expression in human visual cortex. The findings are timely
because novel MRI techniques are driving renewed interest in the
role of myelin function in human cortex (Glasser et al., 2014).
Furthermore, the changes in Golli-MBP expression in human
visual cortex raise new questions about its role as a molecular
link between neural and immune systems at different stages of
the lifespan.
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